Royalty Pharma plc
RPRXA primary-source company identity page built for fast discovery, filing verification and consistent financial research.
A recent price could not be verified. Check the exchange before trading.
Four checks before any decision
Business model
Understand how the company earns and where demand originates.
Revenue and margin
Compare equivalent periods; separate growth from profitability.
Debt and cash flow
Test balance-sheet resilience and cash conversion.
Valuation and risk
Use sector peers, scenarios and explicit risk limits.
Company calendar
Royalty Pharma third-quarter 2026 results
Royalty Pharma will report its third-quarter 2026 results before U.S. financial markets open on November 4. The exact publication time was not specified; portfolio receipts, new royalty investments and funding activity will be in focus.
Royalty Pharma ↗Royalty Pharma Q3 2026 earnings call
Royalty Pharma management's third-quarter earnings call begins at 08:00 EST on November 4, equivalent to 16:00 in Istanbul.
Royalty Pharma ↗Royalty Pharma Q4 dividend record date
The Q4 dividend of $0.235 per Class A ordinary share before tax has a November 13 close-of-business record date and December 10 payment date. Net proceeds depend on investor-specific taxes and other conditions.
Royalty Pharma ↗Royalty Pharma Q4 dividend payment
December 10 is the payment date for the Q4 dividend of $0.235 per Class A ordinary share before tax, based on the November 13 close-of-business record date. Net proceeds depend on investor-specific taxes and other conditions.
Royalty Pharma ↗More NASDAQ records
Alphabetically adjacent directory records for faster navigation; this is not a peer or valuation classification.
Checking SEC financial statements
A dash means standardized data is unavailable. Always check the filing period, currency and accounting scope.